Question 1

What makes Tirzepatide different from Semaglutide?

Accepted Answer

Semaglutide only targets the GLP-1 receptor. Tirzepatide targets both the GLP-1 and GIP receptors, resulting in synergistic lipolysis and vastly different adipose tissue modulation in lab models.

Question 2

What is the half-life of Tirzepatide?

Accepted Answer

Thanks to its C20 fatty diacid moiety, Tirzepatide has an estimated biological half-life of approximately 5 days in mammalian models.

Question 3

Is Tirzepatide safe for human consumption?

Accepted Answer

No. Melbourne Peptides supplies Tirzepatide exclusively for in-vitro laboratory research and analytical modeling.